Silence Therapeutics plc (SLN)

Silence Therapeutics Revenue

Silence Therapeutics had revenue of $224.00K in the quarter ending June 30, 2025, a decrease of -70.37%. This brings the company's revenue in the last twelve months to $27.17M, up 22.28% year-over-year. In the year 2024, Silence Therapeutics had annual revenue of $43.26M with 36.71% growth.

• Revenue (ttm): $27.17M
• Revenue Growth: +22.28%
• P/S Ratio: 10.16
• Revenue / Employee: $234,216
• Employees: 116
• Market Cap: 263.09M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	43.26M	11.62M	36.71%
Dec 31, 2023	31.64M	9.99M	46.12%
Dec 31, 2022	21.66M	4.84M	28.82%
Dec 31, 2021	16.81M	9.33M	124.73%
Dec 31, 2020	7.48M	7.16M	2,214.81%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.